Xiao-Hui Wang (Xiaohui Wang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Liver Metastases

Prognostic Factors

Basal Cell Carcinoma

Top Venues

ImmunoTargets and therapy

Journal of hepatocellular carcinoma

Clinical and translational medicine

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Wang, Ruixia Li, Hui Li, Murong Wang, Juncheng Wang, Xiao-Hui Wang, Qunfang Zhou
Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study. ImmunoTargets and therapy 13 (2024)
Wen-Bin Duan, Xiao-Hui Wang, Guo-Can Zhang, Zhuo He, Shao-Qiang Li, Jie Zhou
Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis. ImmunoTargets and therapy 13 (2024)
Wen-Bin Duan, Xiao-Hui Wang, Guo-Can Zhang, Zhuo He, Shao-Qiang Li, Jie Zhou
Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis. ImmunoTargets and therapy 13 (2024)
Yang Yu, Xiao-Hui Wang, Wen-Jie Hu, De-Hua Chen, Zi-Li Hu, Shao-Qiang Li
Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion. Journal of hepatocellular carcinoma 11 (2024)
Murong Wang, Qunfang Zhou, Hui Li, Mingyu Liu, Ruixia Li, Wei Wang, Xiao-Hui Wang, Jinhua Huang, Feng Duan
Survival Benefit of Lenvatinib Plus PD-1 Inhibitor with or Without HAIC in Advanced Hepatocellular Carcinoma Beyond Oligometastasis: a Multicenter Cohort Study. ImmunoTargets and therapy 13 (2024)
Wei Wang, Ruixia Li, Hui Li, Murong Wang, Juncheng Wang, Xiao-Hui Wang, Qunfang Zhou
Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study. ImmunoTargets and therapy 13 (2024)
Yang Yu, Xiao-Hui Wang, Wen-Jie Hu, De-Hua Chen, Zi-Li Hu, Shao-Qiang Li
Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion. Journal of hepatocellular carcinoma 11 (2024)
Ruixia Li, Xiao-Hui Wang, Hui Li, Murong Wang, Juncheng Wang, Wei Wang, Qunfang Zhou
Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study. Journal of hepatocellular carcinoma 11 (2024)
Chang-Jun Liu, Zhong-Zhi Ma, Wei-Zhi Gong, Xian-Hai Mao, Hao-Quan Wen, Xiao-Hui Wang
The Role of Purine Metabolism-Related Genes PPAT and IMPDH1 in the Carcinogenesis of Intrahepatic Cholangiocarcinoma Based on Metabonomic and Bioinformatic Analyses. Journal of oncology 2023 (2023)
Xiao-Hui Wang, Chang-Jun Liu, Hao-Quan Wen, Xiao-Hui Duan, Yu-Qing Jiao, Yu-Jiang Liu, Min-Shan Chen, Kang-Shun Zhu, Xian-Hai Mao, Qun-Fang Zhou
Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis. Clinical and translational medicine 13 (3) (2023)
Chang-Jun Liu, Zhong-Zhi Ma, Wei-Zhi Gong, Xian-Hai Mao, Hao-Quan Wen, Xiao-Hui Wang
The Role of Purine Metabolism-Related Genes PPAT and IMPDH1 in the Carcinogenesis of Intrahepatic Cholangiocarcinoma Based on Metabonomic and Bioinformatic Analyses. Journal of oncology 2023 (2023)
Xiao-Hui Wang, Chang-Jun Liu, Hao-Quan Wen, Xiao-Hui Duan, Yu-Qing Jiao, Yu-Jiang Liu, Min-Shan Chen, Kang-Shun Zhu, Xian-Hai Mao, Qun-Fang Zhou
Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis. Clinical and translational medicine 13 (3) (2023)
Xiao-Hui Wang, Chang-Jun Liu, Hao-Quan Wen, Xiao-Hui Duan, Yu-Qing Jiao, Yu-Jiang Liu, Min-Shan Chen, Kang-Shun Zhu, Xian-Hai Mao, Qun-Fang Zhou
Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis. Clinical and translational medicine 13 (3) (2023)
Xiao-Hui Wang, Qun-Fang Zhou, Chen-Meng Wang, Cai-Ling Xiang, Ying-Hui Song, Shao-Qiang Li, Min-Shan Chen, Shuang-Lin Xiang, Chang-Jun Liu, Xian-Hai Mao
Adjuvant transarterial chemoembolization for intermediate-stage hepatocellular carcinoma with microvascular invasion. The British journal of surgery (2022)
Xiao-Hui Wang, Zi-Li Hu, Yi-Zhen Fu, Jing-Yu Hou, Wen-Xuan Li, Yao-Jun Zhang, Li Xu, Qun-Fang Zhou, Min-Shan Chen, Zhong-Guo Zhou
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection. Journal of gastroenterology 57 (3) (2022)
Zi-Li Hu, Xuqi Sun, Jie Mei, Zhiwen Hu, Ziliang Yang, Jingyu Hou, Yizhen Fu, Xiao-Hui Wang, Minshan Chen
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients. Journal of hepatocellular carcinoma 9 (2022)
Xiao-Hui Wang, Qing-Bo Liu, Cai-Ling Xiang, Xian-Hai Mao, Bing Yang, Qiang Li, Qun-Fang Zhou, Shao-Qiang Li, Zhong-Guo Zhou, Min-Shan Chen
Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma. International journal of cancer 149 (1) (2021)